Two new markers for treatment efficacy: one for chemo,one for antiangiogenesis
From the American Association for Cancer Research news releases:
The more advanced (available) of the 2 new makers is for chemo effectiveness & is called OncoPlanTM : http://www.aacr.org/Default.aspx?p=1066&d=653 Test Helps Identify Patients with Breast Cancer Who Will Likely Benefit from Chemotherapy, and Those Who Won’t September 15, 2006 The second marker is for effectiveness of antiangiogenesis treatments ( such as Avastin) & is still in research & development: http://www.aacr.org/Default.aspx?p=1275&d=654 Potential Diagnostic Marker Indicates Effectiveness of Anti-angiogenic Drugs September 15, 2006 |
All times are GMT -7. The time now is 09:11 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021